Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trialRenaud Felten, Jacques‐Eric Gottenberg, P. Duffau et al.|Annals of the Rheumatic Diseases|2020Cited by 107
Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent‐onset refractory reactive arthritisAlain Meyer, Emmanuel Chatelus, Daniel Wendling et al.|Arthritis & Rheumatism|2011Cited by 81